Ogata, Yutaka http://orcid.org/0009-0007-5883-8681
Sadahiro, Sotaro
Sakamoto, Kazuhiro
Tsuchiya, Takashi
Takahashi, Takao
Ohge, Hiroki
Sato, Toshihiko
Kondo, Ken
Baba, Hideo
Itabashi, Michio
Ikeda, Masataka
Hamada, Madoka
Maeda, Kiyoshi
Masuko, Hiroyuki
Takahashi, Keiichi
Kusano, Mitsuo
Hyodo, Ichinosuke
Sakamoto, Junichi
Taguri, Masataka
Morita, Satoshi
Funding for this research was provided by:
Taiho Pharmaceutical
Article History
Received: 15 April 2024
Accepted: 28 May 2024
First Online: 4 June 2024
Declarations
:
: The authors declare the following financial interests/personal relationships, which may be considered potential competing interests: Takao Takahashi was awarded an endowed chair from Yakult Honsha outside the submitted work. Outside the submitted work, Hideo Baba received a grant and personal fees from Taiho Pharmaceutical. Outside the submitted work, Ichinosuke Hyodo received grants and personal fees from Taiho Pharmaceutical, Asahi Kasei Pharma, Chugai Pharmaceutical, Eisai, and Ono Pharmaceutical. Satoshi Morita received personal fees outside the submitted work from Bristol-Myers Squibb, Chugai Pharmaceutical, Taiho Pharmaceutical, Eli Lilly Japan, and AstraZeneca. All other authors have no conflicts of interest to declare.
: Not applicable.